Gelomics is a biotechnology service provider focused on 3D cell-culture technology. The company’s core offering is 3D cell culture as part of its service portfolio. According to the report, Gelomics recently completed a $2.2 million seed financing. Participating investors in the round were Queensland Investment Corporation, AngelLoop, and Jelix Ventures. The article does not provide additional operational metrics, founding-year information, or location details.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2024